(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Structure
CAS No.
110548-07-7
Chemical Name:
(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
Synonyms
Levofloxacin-12;Levofloacin Impurity L;(R)-Ofloxacin Carboxylic Acid;(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;(R)-(+)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid;7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3R)-;Levofloxacin impurity 14/(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
CBNumber:
CB33110770
Molecular Formula:
C13H9F2NO4
Molecular Weight:
281.21
MOL File:
110548-07-7.mol
Modify Date:
2022/12/21 16:56:50

(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Properties

Boiling point 459.2±45.0 °C(Predicted)
Density 1.61±0.1 g/cm3(Predicted)
pka 4.87±0.40(Predicted)

(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical Properties,Uses,Production

Uses

The R-enantiomer of Levofloxacin Carboxylic Acid (L360250); an impurity of Levofloxacin. The (S)-enantiomer is substantially the more active.

(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 50)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Venkatasai Life Sciences +91-9908134868 +91-8008303069 Hyderabad, India 186 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
China National Standard Pharmaceutical Corporation Limited +8615391658522 China 11927 58 Inquiry
Tan-Mo Technology Co., Ltd. 19850211281 China 1980 58 Inquiry
Shanghai Zerui Biotechnology Co., Ltd. 021-54580889 18321124657 China 10614 58 Inquiry
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd 18502726233; 18502726233 China 9486 58 Inquiry
BOC Sciences 1-631-485-4226; 16314854226 United States 14059 65 Inquiry
Shenzhen Qingtian Biotechnology Co, Ltd. 18823167005 18162969855 China 2628 58 Inquiry
(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (R)-Ofloxacin Carboxylic Acid Levofloxacin-12 Levofloxacin impurity 14/(R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid (R)-(+)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid Levofloacin Impurity L 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3R)- 110548-07-7